UK markets closed
  • FTSE 100

    6,991.09
    -6.18 (-0.09%)
     
  • FTSE 250

    17,353.28
    -279.36 (-1.58%)
     
  • AIM

    810.22
    -5.98 (-0.73%)
     
  • GBP/EUR

    1.1366
    -0.0031 (-0.28%)
     
  • GBP/USD

    1.1094
    -0.0074 (-0.66%)
     
  • BTC-GBP

    17,491.21
    -687.39 (-3.78%)
     
  • CMC Crypto 200

    442.66
    -12.37 (-2.72%)
     
  • S&P 500

    3,645.70
    -98.82 (-2.64%)
     
  • DOW

    29,337.30
    -589.64 (-1.97%)
     
  • CRUDE OIL

    92.40
    +3.95 (+4.47%)
     
  • GOLD FUTURES

    1,707.00
    -13.80 (-0.80%)
     
  • NIKKEI 225

    27,116.11
    -195.19 (-0.71%)
     
  • HANG SENG

    17,740.05
    -272.10 (-1.51%)
     
  • DAX

    12,273.00
    -197.78 (-1.59%)
     
  • CAC 40

    5,866.94
    -69.48 (-1.17%)
     

Companion Diagnostics Market Worth US$16,056 million by 2031: Visiongain Reports Ltd

·5-min read
Visiongain Reports Ltd
Visiongain Reports Ltd

Global Companion Diagnostics Market Forecast 2021-2031: - Market Segment Product & Services (Assays, Kits & Reagents, and Software & Services) By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NSG), In Situ Hybridization (ISH), Immunohistochemistry (IHC), and Other Technologies), By Indication (Cancer, Infectious Disease, Cardiovascular Diseases, Neurological Diseases, and Other Indications) By End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations (CRO), and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Plus analysis of leading regional/national markets and leading companies in the market. COVID-19 Impact Recovery Analysis (V-shaped recovery, W-shaped recovery, U-shaped recovery, L-shaped recovery)

Global Companion Diagnostics Market Outlook

Visiongain’s lead expert says: ‘The Global Companion Diagnostics Market was valued at US$4,367 million in 2020 and is projected to reach at a market value of US$16,056 million by 2031’.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/cdx-market-2021/#download_sampe_div

Key Questions Answered by this Report:

  • What is the current size of the overall global companion diagnostics market? How much will this market be worth from 2021 to 2031?

  • What are the main drivers and restraints that will shape the overall Companion Diagnostics market over the next ten years?

  • What are the main segments within the overall Companion Diagnostics market?

  • How much will each of these segments be worth for the period 2021 to 2031?

  • How will the composition of the market change during that time, and why?

  • What factors will affect that industry and market over the next ten years?

  • What are the largest national markets for the world Companion Diagnostics?

  • What is their current status and how will they develop over the next ten years?

  • What are their revenue potentials to 2031?

  • How will political and regulatory forces influence regional markets?

  • How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?

  • Who are the leading companies and what are their activities, results, developments and prospects?

  • What are the leading Companion Diagnostics? What are their revenues and latest developments?

  • What are some of the most prominent Companion Diagnostics currently in development?

  • What are the main trends that will affect the world Companion Diagnostics market between 2021 and 2031?

  • What are the main strengths, weaknesses, opportunities and threats for the market?

  • What are the social, technological, economic and political influences that will shape that industry over the next ten years?

  • How will the global Companion Diagnostics market evolve over the forecasted period, 2021 to 2031?

  • What will be the main commercial drivers for the market from 2021 to 2031?

  • How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?

  • How will that industry evolve between 2021 and 2031, especially in R&D?

Companion Diagnostics for Cancer Application is gaining traction in the global market. Find out why. 

Companion diagnostics are appealing for cancer diagnosis because of increasing demand of precision medicine, availability of funding for cancer diagnostics and therapeutics, and increase in R&D activities. Companion diagnostic aids in identifying patients who are most likely to benefit from a cancer therapeutic product. Significant adoption of companion diagnostics for cancer applications has been observed. Major companies and contract manufacturers such as Thermo Fisher Scientific and Roche provide companion diagnostic products for cancer in different countries. Additionally rising demand of personalized medicine and growing use of biomarkers for cancer diagnosis are expected to boost the demand.

Get Detailed TOC @ https://www.visiongain.com/report/cdx-market-2021/#download_sampe_div

Discover sales predictions for the global companion diagnostics market and submarkets.

Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy. Along with revenue prediction for the overall world market, there are 4 segmentation's of the Companion Diagnostics market, with forecasts for 2 products & services, 5 Technologies, 4 Indications, 3 End Users, each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.

Who are the leading players analysed in the market?

  • Abbott Laboratories, Inc.

  • Abnova Corporation

  • Agilent Technologies, Inc.

  • Almac Group

  • Biogenex Laboratories, Inc.

  • bioMérieux SA

  • Danaher Corporation

  • Guardant Health, Inc.

  • Icon Plc

  • Illumina, Inc.

  • Myriad Genetics, Inc.

  • QIAGEN N.V.

  • Roche Diagnostic

  • Sysmex Corporation

  • Thermo Fisher Scientific Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Companion Diagnostics Market and leading companies. You will find data, trends and predictions.

Find more research reports on the Pharmaceutical Industry click on:

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: dev.visavadia@visiongain.com

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:
Dev Visavadia
PR at Visiongain Reports Limited
Tel: + 44 0207 336 6100
Email: dev.visavadia@visiongain.com